“…Moreover, in the present study, the prevalence of non-IOP-related genetic variants in patients with HTG as well as NTG was significantly higher than that observed in the control subjects, indicating that the vulnerability of the RGC/optic nerve owing to non-IOP-related genetic variants also plays an important role in the pathogenesis of HTG, in addition to IOP elevation induced by IOPrelated genetic variants, such as genetic variants near transmembrane and coiled-coiled domains 1 (TMCO1), 18 growth arrest-specific 7 (GAS7), 23 glucocorticoidinduced transcript 1/islet cell autoantigen 1 (GLCCI1/ ICA1), 24 and family with sequence similarity 125, member B (FAM125B). 25 Furthermore, it has been reported that some non-IOP-related genetic variants, such as optic atrophy 1 (OPA1), 26 SRBD1, 21 and CDKN2B/CDKN2B-AS1 22,27,28 genetic variants, contribute to the pathogenesis of HTG as well as NTG; the present results support these findings. Ramdas and associates 12 reported that the VCDR increases as the number of SNPs included in the genetic risk scores associated with VCDR increases and that these genetic risk scores are significantly associated with POAG.…”